SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Boyer David W.

(Last)

(First)

(Middle)

12780 EL CAMINO REAL

(Street)

SAN DIEGO

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2022

3. Issuer Name and Ticker or Trading Symbol
NEUROCRINE BIOSCIENCES INC [ NBIX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Corp. Affairs Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,075	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Incentive Stock Option	⁽¹⁾	10/01/2029	Common Stock	4,480	$89.23	D
Non-Qualified Stock Option	⁽¹⁾	10/01/2029	Common Stock	43,724	$89.23	D
Incentive Stock Option	⁽²⁾	02/06/2030	Common Stock	479	$102.9	D
Non-Qualified Stock Option	⁽²⁾	02/06/2030	Common Stock	11,024	$102.9	D
Incentive Stock Option	⁽³⁾	02/08/2031	Common Stock	1,281	$117.63	D
Non-Qualified Stock Option	⁽³⁾	02/08/2031	Common Stock	33,754	$117.63	D
Incentive Stock Option	⁽⁴⁾	01/31/2032	Common Stock	1,190	$79.02	D
Non-Qualified Stock Option	⁽⁴⁾	01/31/2032	Common Stock	55,907	$79.02	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Common Stock	10,927	⁽⁶⁾	D
Restricted Stock Unit	⁽⁷⁾	⁽⁷⁾	Common Stock	1,823	⁽⁶⁾	D
Restricted Stock Unit	⁽⁸⁾	⁽⁸⁾	Common Stock	5,314	⁽⁶⁾	D
Restriced Stock Unit	⁽⁹⁾	⁽⁹⁾	Common Stock	8,384	⁽⁶⁾	D

Explanation of Responses:

1. Option granted October 1, 2019 and vests at 25% upon first anniversary (October 1, 2020) and remaining 75% vesting in 36 equal monthly installments beginning November 1, 2020.

2. Option granted February 6, 2020 and vests monthly over four years.

3. Option granted February 8, 2021 and vests monthly over four years.

4. Option granted January 31, 2022 and vests monthly over four years.

5. 1/4 of the Restricted Stock Units vested on October 1, 2020 and October 1, 2021. The remaining units vest equally on each of October 1, 2022, October 1, 2023.

6. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.

7. 1/4th of the Restricted Stock Units vested on February 6, 2021. The remaining units vest equally on each of February 6, 2022, February 6, 2023, February 6, 2024.

8. The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 8, 2022, February 8, 2023, February 8, 2024, and February 8, 2025.

9. The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of January 31, 2023, January 31, 2024, January 31, 2025, January 26, 2026.

Remarks:

	/s/ David Boyer	02/09/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.